FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileLumos Diagnostics Holdings Limited
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
LDX.AX
Lumos Diagnostics Holdings Limited Stock AnalysisComprehensive stock analysis for Lumos Diagnostics Holdings Limited (LDX.AX) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisLDX.AX
LDX.AX
Lumos Diagnostics Holdings Limited
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
LDX.AX
  1. Home
  2. Stocks
  3. Lumos Diagnostics Holdings Limited

Lumos Diagnostics Holdings Limited

🇦🇺LDX.AX•ASX

Lumos Diagnostics Holdings Limited

🇦🇺LDX.AX•ASX

Your view on LDX.AX

Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Lumos Diagnostics Holdings Limited

Industry
Medical - Specialties
Sector
Healthcare
CEO
Douglas Ward
Headquarters
Suite 2, Level 11, 385 Bourke Street, Melbourne, VIC, AU
Industry
Medical - Specialties
Sector
Healthcare
CEO
Douglas Ward
Headquarters
Suite 2, Level 11, 385 Bourke Street, Melbourne, VIC, AU
Description

Lumos Diagnostics Holdings Limited develops, manufactures, and commercializes point-of-care diagnostic products for diagnosis and management of infectious diseases in the United States.

The company’s products include FebriDx, a point-of-care diagnostic test for detecting and differentiating viral and bacterial respiratory infections; and ViraDx, a three-in-one point-of-care test for influenza A, influenza B, and COVID-19.

It also provides assay development and manufacturing services for point-of-care tests and proprietary digital reader platforms. Lumos Diagnostics Holdings Limited was incorporated in 2018 and is based in Carlsbad, California.

Financial Data

Stock Data

Price chart, volume, and trading data.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Lumos Diagnostics Holdings Limited. Starting points for Lumos Diagnostics Holdings Limited: EPS -AUD 0.0053, beta 0.55 — an Medical - Specialties name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for Lumos Diagnostics Holdings Limited. Lumos Diagnostics Holdings Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Lumos Diagnostics Holdings Limited. Trailing twelve-month EPS for Lumos Diagnostics Holdings Limited stands at -AUD 0.0053. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Lumos Diagnostics Holdings Limited. Lumos Diagnostics Holdings Limited has reported as a listed company since 2021. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold LDX.AX12 companies
More Medical - Specialties companies
TickerTypeCompanySectorExchangeMkt cap
IDTAIDenta Corp.HealthcareOTC$1.1M
IMR.AXImricor Medical Systems, Inc.HealthcareASX—
ITOCiTonic Holdings Ltd.HealthcareNASDAQ$10.9M
KKURChromoCure, Inc.HealthcareOTC$8,200
LABStandard BioTools Inc.HealthcareNASDAQ$249.1M
LANZLancer Orthodontics, Inc.HealthcareOTC$74,488
LDXHFLumos Diagnostics Holdings LimitedHealthcareOTC$158.6M
LLBOLifeline Biotechnologies, Inc.HealthcareOTC$1.7M
MASS908 Devices Inc.HealthcareNASDAQ$360.5M
MDAISpectral AI, Inc.HealthcareNASDAQ$33.5M
MEDGFMedacta Group S.A.HealthcareOTC$1.7B
MLABMesa Laboratories, Inc.HealthcareNASDAQ$719.0M
Ownership & News

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Lumos Diagnostics Holdings Limited. Coverage tracks Lumos Diagnostics Holdings Limited within Medical - Specialties (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Lumos Diagnostics Holdings Limited.

LDX.AX AnalysisWeak
Past
1
Growth
1
Health
4
Profit
1
Value
1